✦ LIBER ✦

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial

✍ Scribed by Muzaffar H. Qazilbash; Rima M. Saliba; Yago Nieto; Gaurav Parikh; Matteo Pelosini; Fatima B. Khan; Roy B. Jones; Chitra Hosing; Floralyn Mendoza; Donna M. Weber; Michael Wang; Uday Popat; Amin Alousi; Paolo Anderlini; Richard E. Champlin; Sergio Giralt

Book ID: 116280460
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 356 KB
Volume: 14
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2008.09.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

19: Arsenic trioxide with ascorbic acid

19: Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma

✍ M.H. Qazilbash; S. Jindani; Z. Gul; R. Saliba; C. Hosing; F. Mendoza; S.P. Qures 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Arsenic trioxide in combination with asc

Arsenic trioxide in combination with ascorbic acid and high-dose melphalan is safe for patient with mm undergoing an autologous transplant

✍ F.R. Libunao; L.X. Roden; M.S. Davis; R. Champlin; S. Giralt; M. Qazilbash 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase II trial of arsenic trioxide in

A phase II trial of arsenic trioxide in patients with metastatic melanoma

✍ Kevin B. Kim; Agop Y. Bedikian; Luis H. Camacho; Nicholas E. Papadopoulos; Cecil 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Efficacy and safety of melphalan, arseni

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study

✍ James R. Berenson; Ralph Boccia; David Siegel; Marek Bozdech; Alberto Bessudo; E 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Phase II study of arsenic trioxide and a

Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

✍ JE Chang; PM Voorhees; JM Kolesar; HG Ahuja; FA Sanchez; GA Rodriguez; K Kim; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Arsenic trioxide (As 2 O 3 ) has established clinical activity in acute promyelocytic leukaemia and has pre-clinical data suggesting activity in lymphoid malignancies. Cell death from As 2 O 3 may be the result of oxidative stress. Agents which deplete intracellular glutathione, such as ascorbic aci

A Prospective, Open-Label Safety and Eff

A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients with Relapsed or Refractory Multiple Myeloma

✍ Berenson, James R.; Swift, Regina A.; Ferretti, Delina; Purner, Matthew B. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 99 KB